The global Plasma Derived Factor VIII Market is experiencing significant growth as healthcare systems continue to improve the diagnosis and treatment of hemophilia A and other bleeding disorders. Plasma-derived Factor VIII concentrates are essential replacement therapies used to prevent and control bleeding episodes in patients with Factor VIII deficiency. Despite the growing availability of...